Corin Share Discussion Threads

[deckergj] 14/6/2005 19:28

Power, thanks for the info

DJ

[m.t.glass] 13/6/2005 11:21

I see CRG is one of the many seaq stocks becoming a sets/mm stock next month ;o(

[power] 08/6/2005 12:14

As a professional in hip arthroplasty I beleive they will find it difficult if not impossible to obtain FDA approval, despite their decade of statistical evidence. Metal bearing surfaces in orthopaedics have an unpleasant history; wherein metal wear fragments invade body tissue surrounding the joint space. Long term results are bad. The FDA will bring this evidence into consideration, especially when the insurance companies apply pressure. US medicine is increasingly driven by the legal profession, and they may not take a positive view of the negative statistical evidence.
I wouldnt think it wise to buy this share based upon the dream of FDA approval.

[pcok] 08/6/2005 11:34

Ta for all the input MT. I just received a posted copy of the investor day presentation so will peruse and feedback.

I sold most of mine a little while ago (a profit is a profit) but bought a few back last week and will decide on more soon. At the least I will be watching this story closely.

pcok

[m.t.glass] 07/6/2005 15:45

Cashed in mine today, for now.

[m.t.glass] 02/6/2005 11:18

hip hip hip.. three announcements this morning:



Corin Group PLC
02 June 2005

PRESENTATION TO ANALYSTS AND INVESTORS

Corin Group PLC, the innovative developer, manufacturer and distributor of a
wide range of reconstructive orthopaedic devices, is today holding an analyst
and investor presentation. The presentations will cover the activities of
Acrobot, a research and development company in which Corin has an interest
together with Corin's own proprietary products.

2 June 2005

Enquiries:
College Hill 020 7457 2020
Adrian Duffield/Clare Warren



---------------------------------------------------------------------------

Corin Group PLC
02 June 2005

CORIN LAUNCHES OPERATION IN CHINA

Corin Group PLC, a leading innovative developer, manufacturer and global
distributor of a wide range of reconstructive orthopaedic devices announces
today the opening of a subsidiary company in Shanghai, PRC, Corin China. The
operation has been established in order to access the rapidly growing market in
China for orthopaedic devices.

Corin has been selling its devices in China for over 10 years, Corin China
strengthens the Group's existing trading platform in this region. Although the
Group will continue to sell through existing stocking distributors, opening a
direct operation enables Corin to hold stock locally, thereby reducing the time
to market.

Corin now has 9 overseas subsidiaries in territories which account for over 80%
of the worldwide spend on orthopaedic devices. Establishing Corin China
continues the Group's stated strategy of setting up direct sales subsidiaries in
the most important orthopaedic markets worldwide.

Simon Hartley, Group Finance Director commented

'China is clearly an important and rapidly growing market for orthopaedic
devices. This initiative will allow us to provide further focus on our
proprietary metal on metal hips and mobile bearing knee portfolios, in a market
that will eventually become second only in size to the USA. The establishment of
Corin China is a natural continuation of our policy to establish subsidiary
companies in the world's most important orthopaedic markets.'


Corin Group PLC
Ian Paling, Chief Executive 01285 659 866
Simon Hartley, Finance Director

College Hill 020 7457 2020
Clare Warren/Adrian Duffield


--------------------------

CORIN SIGNS COLLABORATION AGREEMENT TO DEVELOP A UNIQUE SPINAL DISC DEVICE

Corin Group PLC, a leading manufacturer and supplier of orthopaedic devices
including a wide range of reconstructive orthopaedic devices, has signed a
collaboration agreement to develop a Percutaneous Disc Nucleus device for spinal
surgery with a consortium consisting of Scottish Health Innovations Limited, NHS
Grampian, University of Birmingham, Heriot Watt University and The Robert Gordon
University. Corin will have exclusive, worldwide rights to exploit the device,
once fully developed and approved.

The collaboration focuses on developing a novel artificial disc nucleus device
from a concept created by Mr Douglas Wardlaw, a Consultant Spinal Surgeon at NHS
Grampian. It is anticipated that this state of the art, minimally invasive
surgical device will accurately mimic the natural vertebral disc nucleus and
return the spine to a near normal anatomy.

It is intended that patients receiving this innovative treatment would be day
case rather than in-patient cases. They would return to a normal life style
quicker than with current treatments, and have a full range of pain free
flexibility.

The three year development project commences on 7th June 2005 and will receive a
substantial grant from the Health Technology Devices Programme, a new Department
of Health research and development programme focussing on healthcare
technologies.

Although there is no immediate impact on Corin or its trading activities, once
developed this technology will enhance the Group's proprietary product portfolio
for niche products aimed at the young active patient with chronic back pain.

Ian Paling, Corin Chief Executive, said:

'There is a great deal of interest in disc replacements for spinal surgery as
the market moves into a new era of non-fusion technology. This collaboration
allows Corin to actively participate in this area with premier educational
institutions and to develop a minimally invasive, day surgery device to address
the growing problem of back pain. We believe that this technology will further
enhance Corin's reputation as a developer of leading edge technologies to meet
the demanding needs of the young active arthritic patient.'
2 June 2005

Enquiries:

Corin Group PLC
Ian Paling, Chief Executive 01285 659 866
Simon Hartley, Finance Director

College Hill
Adrian Duffield/Clare Warren 020 7457 2815/2055

[pcok] 21/5/2005 22:27

Upward climb resumed.

[m.t.glass] 27/4/2005 11:03

Does Claudio Ranieri work for Fidelity? They are forever tinkering with all their holdings. Quite a few of their adjustments are too small to actually require an RNS annoncement - but they put them out anyway. Maybe they just like seeing their name in print.

Their holding in Corin has been one-seventh of the company since last summer, and still is.
Schroder (I think) still own over a fifth. Artemis about 5%(?)

[pcok] 26/4/2005 10:43

I don't know but somebody likes this share at the moment. Lets hope they know something we only suspect as it seems to have strong legs and is climbing that hill. Luvverly.

pcok

[m.t.glass] 22/4/2005 18:38

yep - almost like it's had new joints fitted ;o)
All that positive divergence in RSI through Jan Feb which prompted my buy when confirmed early March..

Don't know if late surge tonight means announcement Monday (re recent climb) but maybe worth watching Monday morning (unless someone knows of some other news or tip out already?)
Last October's prospective takeover back on again?

[pcok] 20/4/2005 09:25

Running again!

[m.t.glass] 20/4/2005 07:45

"...Among the smaller companies, Corin Group, the orthopaedic devices specialist, gained 15p to close at 352p on rumours of a bid approach. Corin held takeover talks with a mystery suitor last year but they ended in a disagreement over price..." (The Guardian, 20 April)




(Here's what the company said last October:

"...The Board of Corin notes the recent movement in the Company's share price. The Board confirms that it has received an approach from a third party, which may or may not lead to an offer being made for the Company... Discussions are at an early stage and there can be no certainty that an offer will ultimately be made.."

This was followed by an announcement saying the talks had ended)

[m.t.glass] 19/4/2005 15:45

Chunky deals generating good volume behind today's strong rise. Be nice if it stays above that bunch of November peaks.

[pcok] 18/4/2005 19:05

On a very red day CRG shows a blue finish...above 330.

mmmm..

[deckergj] 18/4/2005 07:51

MT
Could not agree more, steady does it, when the USA gives its approval then things will start to move quite quickly, imop
DJ

[m.t.glass] 17/4/2005 13:33

"..Shares in Corin Group, a maker of orthopaedic devices, have enjoyed a strong run but may have further to go as the company appears on track for regulatory approval for some of its products in the United States. Profits rose 14% in the last financial year with margins boosted by an increased trend for direct sales. Shares are not cheap but still worth tucking away at 336.5p..." (S.Tgraf, 17 April)

Good to see the mainstream press taking notice.

[m.t.glass] 15/4/2005 14:41

Good innit ;o)
Good volume too
Edit: - with delayed buys now coming through.

[pcok] 15/4/2005 14:24

On a big market down day CRG has smashed through 330.

[m.t.glass] 14/4/2005 10:35

And it did. Looking for it to close at or above 330 today.

[pcok] 12/4/2005 09:57

Now descending the escalator. Hopefully will get off soon.

pcok

[smurombe] 10/4/2005 22:15

I suspect corin have been or will be on the road-show to financial institutions, hence the rise in the share price. (only my opinion)

[deckergj] 08/4/2005 19:27

mtg,

like yourself i searched for any info,whatever the size or content but found nowt. never mind up rather than down on no releases

DJ

[m.t.glass] 08/4/2005 13:06

--> DJ
Dunno. had a lookaround various news sources and found nothing. The trade pattern is consistent with with it having appeared in some subsrciption newsletter someplace maybe. I haven't seen any new brokers note and not heard any press statements emerging from conferences etc.

mtg